STERIS plc (Ireland) - stock earnings

STE Quarterly earnings

DateEarningsRevenue
2023Q4 140.7 million USD 1.4 billion USD
2023Q3 115.3 million USD 1.3 billion USD
2023Q2 123.6 million USD 1.3 billion USD
2023Q1 187.2 million USD 1.4 billion USD
2022Q4 123.3 million USD 1.2 billion USD
2022Q3 -315.2 million USD 1.2 billion USD
2022Q2 110.8 million USD 1.2 billion USD
2022Q1 52.1 million USD 1.2 billion USD
2021Q4 143.1 million USD 1.2 billion USD
2021Q3 69.6 million USD 1.2 billion USD
2021Q2 -21.9 million USD 968.4 million USD
2021Q1 87.4 million USD 873.5 million USD
2020Q4 114.6 million USD 808.9 million USD
2020Q3 105.9 million USD 756.1 million USD
2020Q2 88.2 million USD 668.9 million USD
2020Q1 123.3 million USD 823.0 million USD
2019Q4 104.9 million USD 774.3 million USD
2019Q3 94.8 million USD 736.8 million USD
2019Q2 84.6 million USD 696.8 million USD
2019Q1 108.7 million USD 768.2 million USD
2018Q4 47.9 million USD 696.2 million USD
2018Q3 70.0 million USD 638.8 million USD
2018Q2 70.0 million USD 638.8 million USD
2018Q1 73.6 million USD 716.0 million USD
2017Q4 94.8 million USD 661.9 million USD
2017Q3 58.1 million USD 608.0 million USD
2017Q2 58.1 million USD 608.0 million USD
2017Q1 26.1 million USD 681.2 million USD
2016Q4 -5.0 million USD 646.8 million USD
2016Q3 48.4 million USD 638.4 million USD
2016Q2 48.4 million USD 638.4 million USD
2016Q1 57.7 million USD 690.3 million USD
2015Q4 20.0 million USD 618.7 million USD
2015Q3 24.3 million USD 439.9 million USD
2015Q2 24.3 million USD 439.9 million USD
2015Q1 41.4 million USD 501.6 million USD
2014Q4 38.1 million USD 473.2 million USD
2014Q3 24.5 million USD 412.6 million USD
2014Q2 24.5 million USD 412.6 million USD
2014Q1 38.9 million USD 465.3 million USD
2013Q4 28.5 million USD 405.6 million USD
2013Q3 32.3 million USD 367.7 million USD
2013Q2 32.3 million USD 367.7 million USD
2013Q1 41.4 million USD 428.2 million USD
2012Q4 48.1 million USD 380.4 million USD
2012Q3 30.4 million USD 337.0 million USD
2012Q2 30.4 million USD 337.0 million USD
2012Q1 44.2 million USD 390.2 million USD
2011Q4 33.6 million USD 355.2 million USD
2011Q3 28.7 million USD 318.6 million USD
2011Q2 28.7 million USD 318.6 million USD
2011Q1 39.0 million USD 377.8 million USD
2010Q4 21.8 million USD 328.3 million USD
2010Q3 -45.2 million USD 189.0 million USD
2010Q2 -45.2 million USD 189.0 million USD
2010Q1 29.8 million USD 332.1 million USD
2009Q4 41.0 million USD 327.8 million USD
2009Q3 25.5 million USD 283.5 million USD
2009Q2 25.5 million USD 283.5 million USD
2009Q1 27.8 million USD 344.4 million USD
2008Q4 28.6 million USD 319.5 million USD
2008Q3 25.5 million USD 311.6 million USD
2008Q2 25.5 million USD 311.6 million USD
2008Q1 26.1 million USD 375.2 million USD
2007Q4 21.8 million USD 314.0 million USD
2007Q3 13.2 million USD 280.9 million USD
2007Q2 13.2 million USD 280.9 million USD
2007Q1 29.8 million USD 349.8 million USD
2006Q4 21.3 million USD 299.0 million USD
2006Q3 14.7 million USD 265.1 million USD
2006Q2 14.7 million USD 265.1 million USD
2006Q1 8.5 million USD 331.3 million USD
2005Q4 28.1 million USD 287.5 million USD
2005Q3 17.3 million USD 276.7 million USD
2005Q2 17.3 million USD 276.7 million USD
2005Q1 25.0 million USD 315.7 million USD
2004Q4 24.5 million USD 284.4 million USD
2004Q3 17.6 million USD 254.8 million USD
2004Q2 17.6 million USD 254.8 million USD
2004Q1 30.3 million USD 296.1 million USD
2003Q4 27.1 million USD 274.3 million USD
2003Q3 16.5 million USD 259.3 million USD
2003Q2 16.5 million USD 259.3 million USD
2003Q1 26.7 million USD 273.7 million USD
2002Q4 21.5 million USD 244.3 million USD
2002Q3 12.8 million USD 221.4 million USD
2002Q2 12.8 million USD 221.4 million USD
2002Q1 18.6 million USD 244.6 million USD
2001Q4 14.0 million USD 218.6 million USD
2001Q3 4.4 million USD 197.1 million USD
2001Q2 4.4 million USD 197.1 million USD
2001Q1 -16.6 million USD 218.6 million USD
2000Q4 10.4 million USD 204.5 million USD
2000Q3 828000 USD 183.8 million USD
2000Q2 828000 USD 183.8 million USD
2000Q1 -24.2 million USD 190.1 million USD
1999Q4 10.9 million USD 195.1 million USD
1999Q3 9.3 million USD 176.8 million USD
1999Q2 9.3 million USD 176.8 million USD
1999Q1 28.8 million USD 226.9 million USD
1998Q4 23.0 million USD 205.8 million USD
1998Q3 14.3 million USD 173.8 million USD
1998Q2 14.3 million USD 173.8 million USD
1998Q1 20.3 million USD 204.5 million USD
1997Q4 18.2 million USD 186.6 million USD
1997Q3 11.7 million USD 155.1 million USD
1997Q2 11.7 million USD 155.1 million USD
1997Q1 15.9 million USD 170.5 million USD
1996Q4 13.5 million USD 151.0 million USD
1996Q3 -71.6 million USD 127.9 million USD
1996Q2 -71.6 million USD 127.9 million USD
1996Q1 3.9 million USD 25.6 million USD
1995Q4 3.5 million USD 24.2 million USD
1995Q3 2.5 million USD 19.8 million USD
1995Q2 2.5 million USD 19.8 million USD
1995Q1 2.6 million USD 19.6 million USD
1994Q4 2.4 million USD 16.5 million USD
1994Q3 1.8 million USD 13.0 million USD
1994Q2 1.8 million USD 13.0 million USD
1994Q1 1.6 million USD 14.3 million USD
1993Q4 1.4 million USD 12.0 million USD
1993Q3 2.2 million USD 9.1 million USD
1993Q2 2.2 million USD 9.1 million USD
1993Q1 1.1 million USD 8.8 million USD
1992Q4 700000 USD 6.8 million USD
1992Q3 200000 USD 5.0 million USD
1992Q2 200000 USD 5.0 million USD
1992Q1 700000 USD 4.7 million USD
1991Q4 -100000 USD 3.4 million USD
1991Q3 -200000 USD 2.3 million USD
1991Q2 -200000 USD 2.3 million USD
1991Q1 -100000 USD 2.2 million USD
1990Q4 ? USD 2.5 million USD
1990Q3 -100000 USD 1.6 million USD
1990Q2 -100000 USD 1.6 million USD
1990Q1 -100000 USD 2.5 million USD

STE Yearly earnings

DateEarningsRevenue
2023 107.0 million USD 5.0 billion USD
2022 243.9 million USD 4.6 billion USD
2021 397.4 million USD 3.1 billion USD
2020 407.7 million USD 3.0 billion USD
2019 304.1 million USD 2.8 billion USD
2018 290.9 million USD 2.6 billion USD
2017 110.0 million USD 2.6 billion USD
2016 110.8 million USD 2.2 billion USD
2015 135.1 million USD 1.9 billion USD
2014 129.4 million USD 1.6 billion USD
2013 160.0 million USD 1.5 billion USD
2012 136.1 million USD 1.4 billion USD
2011 51.3 million USD 1.2 billion USD
2010 128.5 million USD 1.3 billion USD
2009 110.7 million USD 1.3 billion USD
2008 77.1 million USD 1.3 billion USD
2007 82.2 million USD 1.2 billion USD
2006 70.3 million USD 1.2 billion USD
2005 86.0 million USD 1.1 billion USD
2004 94.2 million USD 1.1 billion USD
2003 79.4 million USD 972.1 million USD
2002 46.2 million USD 866.7 million USD
2001 1.3 million USD 800.1 million USD
2000 10.5 million USD 760.6 million USD
1999 84.9 million USD 797.6 million USD
1998 65.5 million USD 719.7 million USD
1997 -30.6 million USD 587.9 million USD
1996 12.8 million USD 91.2 million USD
1995 8.7 million USD 64.3 million USD
1994 6.3 million USD 45.8 million USD
1993 2.5 million USD 26.7 million USD
1992 ? USD 12.9 million USD
1991 ? USD 8.8 million USD

STE

List: Contenders

Price: $201.54

52 week price:
180.54
254.00

Dividend Yield: 0.01%

5-year range yield:
0.01%
1.13%

Forward Dividend Yield: 1.03%

Payout Ratio: 36.49%

Payout Ratio Range:
12.95%
65.90%

Dividend Per Share: 2.08 USD

Earnings Per Share: 5.69 USD

P/E Ratio: 40.89

Exchange: NYQ

Sector: Healthcare

Industry: Medical Devices

Volume: 489871

Ebitda: 149.1 million

Market Capitalization: 19.9 billion

Average Dividend Frequency: 4

Years Paying Dividends: 20

DGR3: 7.66%

DGR5: 7.98%

DGR10: 8.65%

Links: